Ernexa Therapeutics to join Virtual Investor Closing Bell event

Eterna Therapeutics

Eterna Therapeutics

ERNA

0.00
  • Ernexa Therapeutics to participate in Virtual Investor Closing Bell event on May 13, 2026 at 4:00 PM ET.
  • Event to feature corporate overview from President and CEO Sanjeev Luther, with Chief Scientific Officer Robert Pierce discussing preclinical ovarian cancer results for ERNA-101, including complete tumor elimination and 100% survival in models when combined with PD-1 blockade.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605110915PRIMZONEFULLFEED9716964) on May 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.